205 related articles for article (PubMed ID: 24809349)
1. Timed action of IL-27 protects from immunopathology while preserving defense in influenza.
Liu FD; Kenngott EE; Schröter MF; Kühl A; Jennrich S; Watzlawick R; Hoffmann U; Wolff T; Norley S; Scheffold A; Stumhofer JS; Saris CJ; Schwab JM; Hunter CA; Debes GF; Hamann A
PLoS Pathog; 2014 May; 10(5):e1004110. PubMed ID: 24809349
[TBL] [Abstract][Full Text] [Related]
2. Group 2 innate lymphoid cell production of IL-5 is regulated by NKT cells during influenza virus infection.
Gorski SA; Hahn YS; Braciale TJ
PLoS Pathog; 2013 Sep; 9(9):e1003615. PubMed ID: 24068930
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 limits influenza-induced inflammation and protects against fatal lung pathology.
Lauder SN; Jones E; Smart K; Bloom A; Williams AS; Hindley JP; Ondondo B; Taylor PR; Clement M; Fielding C; Godkin AJ; Jones SA; Gallimore AM
Eur J Immunol; 2013 Oct; 43(10):2613-25. PubMed ID: 23857287
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection.
Schmitz N; Kurrer M; Bachmann MF; Kopf M
J Virol; 2005 May; 79(10):6441-8. PubMed ID: 15858027
[TBL] [Abstract][Full Text] [Related]
5. IL-12 deficiency transiently improves viral clearance during the late phase of respiratory tract infection with influenza A virus in mice.
van der Sluijs KF; van Elden LJ; Xiao Y; Arens R; Nijhuis M; Schuurman R; Florquin S; Jansen HM; Lutter R; van der Poll T
Antiviral Res; 2006 Jun; 70(2):75-84. PubMed ID: 16490265
[TBL] [Abstract][Full Text] [Related]
6. Intranasal Introduction of Fc-Fused Interleukin-7 Provides Long-Lasting Prophylaxis against Lethal Influenza Virus Infection.
Kang MC; Choi DH; Choi YW; Park SJ; Namkoong H; Park KS; Ahn SS; Surh CD; Yoon SW; Kim DJ; Choi JA; Park Y; Sung YC; Lee SW
J Virol; 2015 Dec; 90(5):2273-84. PubMed ID: 26656713
[TBL] [Abstract][Full Text] [Related]
7. Paracetamol reduces influenza-induced immunopathology in a mouse model of infection without compromising virus clearance or the generation of protective immunity.
Lauder SN; Taylor PR; Clark SR; Evans RL; Hindley JP; Smart K; Leach H; Kidd EJ; Broadley KJ; Jones SA; Wise MP; Godkin AJ; O'Donnell V; Gallimore AM
Thorax; 2011 May; 66(5):368-74. PubMed ID: 21310755
[TBL] [Abstract][Full Text] [Related]
8. Salivary Blockade Protects the Lower Respiratory Tract of Mice from Lethal Influenza Virus Infection.
Ivinson K; Deliyannis G; McNabb L; Grollo L; Gilbertson B; Jackson D; Brown LE
J Virol; 2017 Jul; 91(14):. PubMed ID: 28446669
[TBL] [Abstract][Full Text] [Related]
9. Control of pathogenic CD4 T cells and lethal immunopathology by signaling immunoadaptor DAP12 during influenza infection.
McCormick S; Shaler CR; Small CL; Horvath C; Damjanovic D; Brown EG; Aoki N; Takai T; Xing Z
J Immunol; 2011 Oct; 187(8):4280-92. PubMed ID: 21908731
[TBL] [Abstract][Full Text] [Related]
10. Innate Immune Responses to Influenza Virus Infections in the Upper Respiratory Tract.
Mifsud EJ; Kuba M; Barr IG
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696520
[TBL] [Abstract][Full Text] [Related]
11. The role of IL-27 in susceptibility to post-influenza Staphylococcus aureus pneumonia.
Robinson KM; Lee B; Scheller EV; Mandalapu S; Enelow RI; Kolls JK; Alcorn JF
Respir Res; 2015 Feb; 16(1):10. PubMed ID: 25651926
[TBL] [Abstract][Full Text] [Related]
12. Functional Interplay between Type I and II Interferons Is Essential to Limit Influenza A Virus-Induced Tissue Inflammation.
Stifter SA; Bhattacharyya N; Pillay R; Flórido M; Triccas JA; Britton WJ; Feng CG
PLoS Pathog; 2016 Jan; 12(1):e1005378. PubMed ID: 26731100
[TBL] [Abstract][Full Text] [Related]
13. A detrimental effect of interleukin-10 on protective pulmonary humoral immunity during primary influenza A virus infection.
Sun K; Torres L; Metzger DW
J Virol; 2010 May; 84(10):5007-14. PubMed ID: 20200252
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary immune cells and inflammatory cytokine dysregulation are associated with mortality of IL-1R1
Guo L; Wang YC; Mei JJ; Ning RT; Wang JJ; Li JQ; Wang X; Zheng HW; Fan HT; Liu LD
Zool Res; 2017 May; 38(3):146-154. PubMed ID: 28585438
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 12 administration enhances Th1 activity but delays recovery from influenza A virus infection in mice.
Kostense S; Sun WH; Cottey R; Taylor SF; Harmeling S; Zander D; Small PA; Bender BS
Antiviral Res; 1998 May; 38(2):117-30. PubMed ID: 9707374
[TBL] [Abstract][Full Text] [Related]
16. BCL6 modulates tissue neutrophil survival and exacerbates pulmonary inflammation following influenza virus infection.
Zhu B; Zhang R; Li C; Jiang L; Xiang M; Ye Z; Kita H; Melnick AM; Dent AL; Sun J
Proc Natl Acad Sci U S A; 2019 Jun; 116(24):11888-11893. PubMed ID: 31138703
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection.
Ivanov S; Renneson J; Fontaine J; Barthelemy A; Paget C; Fernandez EM; Blanc F; De Trez C; Van Maele L; Dumoutier L; Huerre MR; Eberl G; Si-Tahar M; Gosset P; Renauld JC; Sirard JC; Faveeuw C; Trottein F
J Virol; 2013 Jun; 87(12):6911-24. PubMed ID: 23596287
[TBL] [Abstract][Full Text] [Related]
18. Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice.
Kudva A; Scheller EV; Robinson KM; Crowe CR; Choi SM; Slight SR; Khader SA; Dubin PJ; Enelow RI; Kolls JK; Alcorn JF
J Immunol; 2011 Feb; 186(3):1666-1674. PubMed ID: 21178015
[TBL] [Abstract][Full Text] [Related]
19. Enhanced viral clearance in interleukin-18 gene-deficient mice after pulmonary infection with influenza A virus.
Van Der Sluijs KF; Van Elden LJ; Arens R; Nijhuis M; Schuurman R; Florquin S; Kwakkel J; Akira S; Jansen HM; Lutter R; Van Der Polls T
Immunology; 2005 Jan; 114(1):112-20. PubMed ID: 15606801
[TBL] [Abstract][Full Text] [Related]
20. Novel protective mechanism for interleukin-33 at the mucosal barrier during influenza-associated bacterial superinfection.
Robinson KM; Ramanan K; Clay ME; McHugh KJ; Rich HE; Alcorn JF
Mucosal Immunol; 2018 Jan; 11(1):199-208. PubMed ID: 28401938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
